Find out more about business development opportunities at Gene Therapy for Neurological Disorders (GTxN).
GTxN is the only industry-focused meeting dedicated to helping drug developers successfully develop gene therapies for CNS indications.
The event will host the field's most important thought-leaders and stakeholders and has been designed to overcome their challenges faced during their gene therapy development. In doing so, GTxN provides you with the platform to:
|Demonstrate your experience in vector engineering and gene therapy development|
|Showcase your high quality preclinical models and novel model innovations to improve the translatability of preclinical research|
|Present your large mammal expertise to CNS decision makers actively seeking more advanced non-rodent models|
|Introduce the latest drug delivery devices to show the potential for successful administration|
|Establish your preclinical experience to improve the predictability of preclinical gene therapy research|
|Reveal how your technology platform may improve the efficiency and accuracy of drug developers research|
There are vast networking opportunities at GTxN which will help you improve your understanding of the gene therapy for CNS landscape and make the right connections with the field's most active pharma and biotechs.